RARE DISEASES / CLINICAL RESEARCH
A novel homozygous ALMS1 protein truncation mutation (c.2938dupA) revealed variable clinical expression among Saudi Alström syndrome patients
More details
Hide details
1
Princess Al Jawhara Albrahim Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia
2
Department of Genetic Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
3
Department of Clinical Laboratory Science, Prince Sultan Military College of Health Science, Dammam, Saudi Arabia
4
Cardiology Department of Medicine, King Abdulaziz University, Jeddah,Saudi Arabia
5
Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
6
Unité de Recherche Cardiogénétique, Service de Médecine Génétique, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Submission date: 2020-05-12
Final revision date: 2020-08-25
Acceptance date: 2020-09-08
Online publication date: 2020-11-05
Publication date: 2026-09-15
Corresponding author
Faten Abdullah Al-Qahtani
Department of Genetic Medicine
King Abdulaziz University
Jeddah, Saudi Arabia
Department of Clinical
Laboratory Science
Prince Sultan Military
College of Health Science
Dammam, Saudi Arabia
Jumana Yousuf Al-Aama
Princess Al Jawhara Albrahim
Center of Excellence in
Research of Hereditary Disorders
King Abdulaziz University
Jeddah, Saudi Arabia
Department of Genetic Medicine
King Abdulaziz University
Jeddah, Saudi Arabia
Arch Med Sci 2026;22(4):2197-2204
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Alström syndrome, ALMS (OMIM 203800) is a rare multi-systemic disease. The characteristic clinical features include blindness due to progressive cone-rod dystrophy, sensorineural hearing loss, type 2 diabetes mellitus, dilated cardiomyopathy, and childhood obesity. The aim of this study was to identify the genetic cause of Alström syndrome in patients who presented with variable clinical characteristics.
Material and methods:
Clinical phenotyping and whole exome sequencing were performed in Saudi Alström syndrome patients. The Sanger sequencing was done to ascertain the segregation of Alström syndrome causative mutation in the family members. The rare prevalence of this mutation was further established by sequencing an additional 100 healthy Saudi controls.
Results:
Whole exome sequencing analysis revealed that Alström syndrome patients have inherited a novel homozygous protein truncating mutation (c.2938dupA) in the ALMS1 gene segregated in an autosomal recessive fashion. This variant was absent in healthy controls. Genotype-phenotype analysis showed its interesting association with intra-familial clinical variability with regards to vision abnormalities, age at onset of dilated cardiomyopathy (DCM), obesity and hearing loss symptoms in the Alström syndrome patients.
Conclusions:
Our findings indicate that the atypical presentation of Alström syndrome, even within siblings, could sometimes lead to clinical misdiagnosis. Hence, the present study emphasizes the utility of exome sequencing to support the clinical diagnosis of Alström syndrome patients.
REFERENCES (23)
1.
Joy T, Cao H, Black G, et al. Alstrom syndrome (OMIM 203800): a case report and literature review. Orphanet J Rare Dis 2007; 2: 49.
2.
Bakar AA, Kamal NM, Alsaedi A, Turkistani R, Aldosari D. Alström syndrome: a novel mutation in Saudi girl with insulin-resistant diabetes. Medicine 2017; 96: e6192.
3.
Colunga Blanco S, Velasco Alonso E, Corros Vicente C, Martín Fernández M, García Pérez L, Morís de la Tassa C. Alström syndrome: a rare cause of cardiomyopathy. Rev Esp Cardiol 2018; 71: 296-8.
4.
Khan AO, Bifari IN, Bolz HJ. Ophthalmic features of children not yet diagnosed with Alstrom syndrome. Ophthalmology 2015; 122: 1726-7.e2.
5.
Poli L, Arroyo G, Garofalo M, et al. Kidney transplantation in Alström syndrome: case report. Transplant Proc 2017; 49: 733-5.
6.
Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. Alström syndrome. GeneReviews® [Internet] 2003 Feb 7 [Updated 2019 Jun 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from:
https://www.ncbi.nlm.nih.gov/b....
7.
Kamal NM, Sahly AN, Banaganapalli B, et al. Whole exome sequencing identifies rare biallelic ALMS1 missense and stop gain mutations in familial Alström syndrome patients. Saudi J Biol Sci 2020; 27: 271-8.
8.
Arbustini E, Narula N, Dec GW, et al. The MOGE (S) classification for a phenotype–genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol 2013; 62: 2046-72.
9.
Marshall JD, Muller J, Collin GB, et al. Alström syndrome: mutation spectrum of ALMS1. Hum Mutat 2015; 36: 660-8.
10.
Braune K, Volkmer I, Staege MS. Characterization of alstrom syndrome 1 (ALMS1) transcript variants in hodgkin lymphoma cells. Plos One 2017; 12.
11.
Astuti D, Sabir A, Fulton P, et al. Monogenic diabetes syndromes: locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia. Human Mutation 2017; 38: 764-77.
12.
Hearn T. ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. J Mol Med 2019; 97: 1-17.
13.
Hearn T, Renforth GL, Spalluto C, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 2002; 31: 79-83.
14.
Lindsey S, Brewer C, Stakhovskaya O, et al. Auditory and otologic profile of Alström syndrome: comprehensive single center data on 38 patients. Am J Med Genet C Semin Med Genet 2017; 173: 2210-8.
15.
Zmyslowska A, Borowiec M, Antosik K, et al. Genetic evaluation of patients with Alström syndrome in the Polish population.Clin Genet 2016; 89: 448-53.
17.
Marshall JD, Maffei P, Collin G, Naggert J. Alstrom syndrome: genetics and clinical overview. Curr Genomics 2011; 12: 225-35.
18.
Girard D, Petrovsky N. Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 2011; 7: 77-88.
19.
Chen JH, Geberhiwot T, Barrett TG, Paisey R, Semple RK. Refining genotype-phenotype correlation in Alström syndrome through study of primary human fibroblasts. Mol Genet Genomic Med 2017; 5: 390-404.
20.
Safieh LA, Al-Otaibi HM, Lewis RA, Kozak I. Novel mutations in two Saudi patients with congenital retinal dystrophy. Middle East Afr J Ophthalmol 2016; 23: 139-41.
21.
Aldahmesh MA, Abu-Safieh L, Khan AO, et al. Allelic heterogeneity in inbred populations: the Saudi experience with Alström syndrome as an illustrative example. Am J Med Genet A 2009; 149A: 662-5.
22.
Wang X, Wang H, Cao M, et al. Whole-exome sequencing identifies ALMS1, IQCB1, CNGA3, and MYO7A mutations in patients with Leber congenital amaurosis. Hum Mutat 2011; 32: 1450-9.
23.
Li G, Vega R, Nelms K, et al. A role for Alström syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 2007; 3: e8.